Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients

被引:133
作者
Boeckh, M [1 ]
Bowden, RA [1 ]
Gooley, T [1 ]
Myerson, D [1 ]
Corey, L [1 ]
机构
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
关键词
D O I
10.1182/blood.V93.5.1781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1781 / 1782
页数:2
相关论文
共 3 条
[1]   Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study [J].
Boeckh, M ;
Gooley, TA ;
Myerson, D ;
Cunningham, T ;
Schoch, G ;
Bowden, RA .
BLOOD, 1996, 88 (10) :4063-4071
[2]  
EINSELE H, 1995, BLOOD, V86, P2815
[3]   RECOVERY OF HLA-RESTRICTED CYTOMEGALOVIRUS (CMV)-SPECIFIC T-CELL RESPONSES AFTER ALLOGENEIC BONE-MARROW TRANSPLANT - CORRELATION WITH CMV DISEASE AND EFFECT OF GANCICLOVIR PROPHYLAXIS [J].
LI, CR ;
GREENBERG, PD ;
GILBERT, MJ ;
GOODRICH, JM ;
RIDDELL, SR .
BLOOD, 1994, 83 (07) :1971-1979